General Course Fee: $99
Opioids CME Credit
This program in its entirety provides 3 hours (0.3 CEU) of ACPE CPE home study credit, AMA Category 2 CME, and CNE pharmacology credit.
Course Expiration Date
This program, Opioids, Cannabinoids and Gabapentenoids: Defining the Best Pharmacological Practice Model for the Treatment, was originally presented and recorded September 16, 2020 during a continuing education webinar for health professionals.
At the conclusion of this session, the participant will be able to:
- Discuss the burden of opioid misuse and abuse on the individual and society.
- Differentiate addiction, physical dependency, tolerance and hyperalgesia.
- Describe the similarities and differences in the mechanism of action for opioids, cannabinoids and gabapentenoids.
- Compare and contrast the current best practice model for the use of opioids, cannabinoids and gabapentenoids in: a) acute postoperative pain; b) chronic low back pain; c) neuropathic pain; d) fibromyalgia; e) end-of-life pain crisis.
- Identify typical characteristics of patients who would be identified as “high risk”, “moderate risk” and “low risk” for misusing, abusing or diverting opioids.
- Describe the best practice model for properly monitoring patients on opioids.
- Describe how a provider should counsel patients who are started on opioids to minimize the risks of adverse reactions, over-dosage and inappropriate compliance.
- Identify examples of opioids products that have “abuse-deterrent” technology and be able to recommend to prescribers how these products could be utilized to improve patient and community safety.
- Compare and contrast the most common cannabinoids found in marijuana with regards to their benefits and risks in managing pain.
- Compare and contrast the following gabapentenoids with respect to their benefits and risks in managing pain: a) gabapentin (Neurontin); b) Horizant; c) Gralise; and, d) Lyrica.
- Describe the risks of combining opioids with: a) benzodiazepines; b) alcohol; c) gabapentenoids; and, d) cannabinoids.
- Describe the role of naloxone in preventing deaths from overdosages.
Gregory L. Holmquist, Pharm D.
Pain and Palliative Care Pharmacist Specialist, Palliative Care Strategies, Everett, Washington.
- Register online by clicking here.
- Your emailed course confirmation will contain the pertinent information for completing this online learning course.
- Once registered, you may watch our self paced continuing education course on your computer or mobile device.
- Please use the links, included in your emailed confirmation, to download the course handout and complete the course post test and evaluation.
Requirements for Credit
For ACPE, ANCC or AMA Category 2 Credit, you must receive a score of 70% or greater on the multiple choice test and and complete the written course evaluation.
Please complete and test and evaluation online. ULS will receive notification of course completion, and will mail your statement of credit.*
*Pharmacists: Please ensure that we have your NABP# and date of birth on file. ACPE does not allow us to provide you with paper Statements of Credit. Should you need a paper statement of credit, you can access that information via CPE Monitor. All other professionals: An applicable paper Statement of Credit will be issued upon receipt of your post-conference paperwork.
Obtaining CE Credit
Once your course is completed and accreditation requirements have been met, ULS will receive notification of course completion, and email your statement of credit (physicians, physician assistants, nurses, nurse practitioners, and non-US health professionals), report credit to CPE Monitor (pharmacists) and report credit to other organizations that you specify such as CE Broker. Please provide all necessary reporting information at the time of registration.
Accreditation/ Target Audience
This course provides three (3) hours of AMA Category 2 credit.
American Osteopathic Association (AOA): This course provides three (3) hours of AMA Category 2 credit.
Members of the College of Family Physicians of Canada CFPC : This course provides three (3) hours of AMA Category 2 credit.
American Academy of Physician Assistants (AAPA): This course provides three (3) hours of AMA Category 2 credit.
American Nurses Credentialing Center (ANCC): Continuing education hours approved by ACPE meet the ANCC-accredited CNE criteria. This course provides pharmacology/pharmacotherapeutics Category 1 Continuing Education Hours for certification renewal. The same hours submitted to renew certification may be submitted to a State Board of Nursing for re-licensure.
National Certification Corporation (NCC): Recognizes any Nursing, Medical, Health Care or Other For Profit or Not for Profit Education Provider. Please contact NCC regarding approval.
American Academy of Nurse Practitioners Certification Program (AANPCP): National Certification Program for Nurse Practitioners accepts ACPE credit.
University Learning Systems is approved by the California Board of Registered Nursing, Provider Number CEP 11409.
University Learning Systems (ULS), is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education. All ULS courses carry ACPE credit with the designation for pharmacists (P). Online courses are recognized as home study courses by ACPE.
Title: Opioids, Cannabinoids and Gabapentenoids: Defining the Best Pharmacological Practice Model for the Treatment
Activity Type: Knowledge
CEU: 3 hours
Canadian Council on Continuing Education in Pharmacy (CCCEP) accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE).
Other Health Professionals
Contact your respective board regarding approval.